Group One Trading
KYNB

Group One Trading’s Kyntra Bio KYNB Stock Holding History

Group One Trading’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.8K Buy
7,200
+2,100
+41% +$16.4K ﹤0.01% 5275
2025
Q4 		$44.8K Buy
5,100
+500
+11% +$4.89K ﹤0.01% 5692
2025
Q3 		$56.4K Sell
4,600
-54,500
-92% -$512K ﹤0.01% 5858
2025
Q2 		$313K Buy
59,100
+56,644
+2,306% +$413K ﹤0.01% 3879
2025
Q1 		$19K Sell
2,456
-3,800
-61% -$45.6K ﹤0.01% 5844
2024
Q4 		$82.8K Buy
6,256
+1,556
+33% +$14.5K ﹤0.01% 4667
2024
Q3 		$46.9K Buy
4,700
+888
+23% +$13.4K ﹤0.01% 4699
2024
Q2 		$85K Sell
3,812
-784
-17% -$24.2K ﹤0.01% 4091
2024
Q1 		$270K Buy
4,596
+3,920
+580% +$169K ﹤0.01% 3300
2023
Q4 		$15K Sell
676
-156
-19% -$2.35K ﹤0.01% 5948
2023
Q3 		$17.9K Sell
832
-25,008
-97% -$982K ﹤0.01% 5961
2023
Q2 		$1.74M Buy
25,840
+25,044
+3,146% +$10.4M 0.01% 1841
2023
Q1 		$371K Sell
796
-2,072
-72% -$1.1M ﹤0.01% 3036
2022
Q4 		$1.15M Buy
2,868
+456
+19% +$175K ﹤0.01% 2292
2022
Q3 		$785K Buy
2,412
+1,680
+230% +$541K ﹤0.01% 2808
2022
Q2 		$193K Sell
732
-580
-44% -$148K ﹤0.01% 4345
2022
Q1 		$394K Buy
1,312
+108
+9% +$37.6K ﹤0.01% 4067
2021
Q4 		$424K Sell
1,204
-828
-41% -$258K ﹤0.01% 4321
2021
Q3 		$519K Sell
2,032
-76
-4% -$26.9K ﹤0.01% 4149
2021
Q2 		$1.4M Sell
2,108
-3,336
-61% -$1.92M ﹤0.01% 3026
2021
Q1 		$4.72M Buy
5,444
+2,032
+60% +$2.16M 0.01% 1569
2020
Q4 		$3.16M Buy
3,412
+3,048
+837% +$3.2M 0.01% 1660
2020
Q3 		$374K Buy
364
+300
+469% +$323K ﹤0.01% 3105
2020
Q2 		$65K Sell
64
-440
-87% -$409K ﹤0.01% 4195
2020
Q1 		$438K Sell
504
-1,104
-69% -$1.1M ﹤0.01% 2147
2019
Q4 		$1.72M Buy
1,608
+1,100
+217% +$1.12M 0.01% 1408
2019
Q3 		$470K Sell
508
-2,044
-80% -$2.24M ﹤0.01% 2388
2019
Q2 		$2.88M Buy
2,552
+2,004
+366% +$2.19M 0.03% 841
2019
Q1 		$745K Sell
548
-248
-31% -$336K 0.01% 1625
2018
Q4 		$921K Buy
796
+776
+3,880% +$872K 0.01% 1564
2018
Q3 		$30K Sell
20
-516
-96% -$795K ﹤0.01% 4226
2018
Q2 		$839K Sell
536
-112
-17% -$146K 0.01% 1876
2018
Q1 		$748K Buy
648
+92
+17% +$121K 0.01% 1732
2017
Q4 		$659K Sell
556
-8
-1% -$10K ﹤0.01% 2033
2017
Q3 		$759K Buy
564
+20
+4% +$21.1K 0.01% 1764
2017
Q2 		$439K Sell
544
-184
-25% -$128K ﹤0.01% 2066
2017
Q1 		$449K Buy
728
+196
+37% +$119K 0.01% 1914
2016
Q4 		$285K Sell
532
-88
-14% -$43.9K ﹤0.01% 2178
2016
Q3 		$321K Buy
620
+604
+3,775% +$285K ﹤0.01% 2145
2016
Q2 		$7K Sell
16
-120
-88% -$54.9K ﹤0.01% 4180
2016
Q1 		$72K Sell
136
-124
-48% -$61.8K ﹤0.01% 3042
2015
Q4 		$198K Buy
260
+156
+150% +$104K ﹤0.01% 2500
2015
Q3 		$57K Sell
104
-76
-42% -$46K ﹤0.01% 3439
2015
Q2 		$106K Buy
+180
New +$105K ﹤0.01% 3037

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's KYNB Position: Q1 2026 in Review

Group One Trading reduced its Kyntra Bio (KYNB) stake by 2.1% in Q1 2026, selling an estimated $751 and leaving 4,492 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5659.

Group One Trading first reported a position in KYNB in Q2 2015 and has held it in 38 quarters since. The position peaked at $5.88M in Q1 2019. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Group One Trading held 4,492 shares of Kyntra Bio worth $30.5K as of Q1 2026.
  • Group One Trading sold 96 Kyntra Bio shares in Q1 2026, an estimated $751.
  • Kyntra Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5659 holding.
  • Group One Trading first reported a position in Kyntra Bio in Q2 2015 and has held it in 38 quarters since.
  • Group One Trading's Kyntra Bio position peaked at $5.88M in Q1 2019.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.